Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

154
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
154
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

247
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
247
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

224
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
224
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

138
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
138
Esophagus01:24

Esophagus

1.1K
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
1.1K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

239
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
239

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thermal ablative therapies in the gastrointestinal tract.

Current opinion in gastroenterology·2023
Same author

eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2022
Same author

Hybrid APC in Combination With Resection for the Endoscopic Treatment of Neoplastic Barrett's Esophagus: A Prospective, Multicenter Study.

The American journal of gastroenterology·2021
Same author

Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.

Carcinogenesis·2020
Same author

Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus: long-term outcome of a randomized trial.

Gastrointestinal endoscopy·2020
Same author

Endoscopic and angiographic management of lower gastrointestinal bleeding: Review of the published literature.

United European gastroenterology journal·2018

Related Experiment Video

Updated: Aug 13, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.1K

[Current status in Barrett's esophagus].

Hendrik Manner

    Deutsche Medizinische Wochenschrift (1946)
    |January 23, 2023
    PubMed
    Summary
    This summary is machine-generated.

    Barrett's esophagus (BE) management has evolved, linking gastroesophageal reflux disease to adenocarcinoma. Current strategies involve individualized surveillance and endoscopic therapy for malignant transformations, with AI emerging.

    More Related Videos

    Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
    06:55

    Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

    Published on: May 11, 2014

    12.1K
    Development of Compendium for Esophageal Squamous Cell Carcinoma
    03:36

    Development of Compendium for Esophageal Squamous Cell Carcinoma

    Published on: April 12, 2024

    507

    Related Experiment Videos

    Last Updated: Aug 13, 2025

    An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
    08:54

    An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

    Published on: July 20, 2014

    14.1K
    Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
    06:55

    Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

    Published on: May 11, 2014

    12.1K
    Development of Compendium for Esophageal Squamous Cell Carcinoma
    03:36

    Development of Compendium for Esophageal Squamous Cell Carcinoma

    Published on: April 12, 2024

    507

    Area of Science:

    • Gastroenterology
    • Oncology
    • Endoscopy

    Context:

    • Barrett's esophagus (BE) is a significant clinical concern.
    • The association between gastroesophageal reflux disease (GERD) and BE was established in the 1970s.
    • BE's link to esophageal adenocarcinoma was reported a decade later.

    Purpose:

    • To review the evolution of Barrett's esophagus management.
    • To highlight current surveillance and treatment strategies.
    • To acknowledge emerging artificial intelligence techniques in BE care.

    Summary:

    • Management of Barrett's esophagus (BE) has advanced significantly since the 1970s.
    • Surveillance protocols for non-neoplastic BE are guideline-defined.
    • Endoscopic therapy is reserved for malignant transformations, including dysplasia and early cancer.
    • Artificial intelligence is an emerging area in BE management.

    Impact:

    • Individualized surveillance and treatment strategies are increasingly adopted for BE patients.
    • Endoscopic resection and ablation are established therapies for BE with malignancy.
    • Keeping abreast of rapid developments is crucial for optimal BE patient outcomes.